Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic Hepatitis B patients

Clinical Immunology

Volumn 139, Issue 1, 2011, Pages 1-5

  Liu, Fen ^a,b   Tong, Fuyi ^c   He, Yan ^a,b   Liu, Haiyan ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c The Affiliated Infectious Diseases Hospital of Soochow University   (China)

Author keywords

CD4+ T cells; Hepatitis B; IL 35; Regulatory T cells

Indexed keywords

INTERLEUKIN 35;

ADULT; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; BLOOD DONORS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS B, CHRONIC; HUMANS; IMMUNOPRECIPITATION; INTERLEUKINS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 79953030082     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.12.012     Document Type: Article

References (20)

1. Schrader J.W. Interleukin is as interleukin does. Trends Immunol. 2002, 23:573-574.
2. Collison L.W., Vignali D.A. Interleukin-35: odd one out or part of the family?. Immunol. Rev. 2008, 226:248-262.
3. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W.M., Mattson J.D., Wagner J.L., To W., Zurawski S., McClanahan T.K., Gorman D.M., Bazan J.F., de Waal Malefyt R., Rennick D., Kastelein R.A. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790.
4. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., Cross R., Sehy D., Blumberg R.S., Vignali D.A. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
5. Collison L.W., Pillai M.R., Chaturvedi V., Vignali D.A. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J. Immunol. 2009, 182:6121-6128.
6. Bardel E., Larousserie F., Charlot-Rabiega P., Coulomb-L'Hermine A., Devergne O. Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J. Immunol. 2008, 181:6898-6905.
7. Devergne O., Coulomb-L'Hermine A., Capel F., Moussa M., Capron F. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am. J. Pathol. 2001, 159:1763-1776.
8. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., Liew F.Y. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 2007, 37:3021-3029.
9. Seyerl M., Kirchberger S., Majdic O., Seipelt J., Jindra C., Schrauf C., Stockl J. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol 2010, 40:321-329.
10. Whalley S.A., Brown D., Webster G.J., Jacobs R., Reignat S., Bertoletti A., Teo C.G., Emery V., Dusheiko G.M. Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants. Gastroenterology 2004, 127:1131-1138.
11. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., Zhao J.M., Zhang B., Shi M., Ding X., Tang Z., Fu Y.X., Wang F.S. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 2006, 177:739-747.
12. Chisari F.V. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am. J. Pathol. 2000, 156:1117-1132.
13. Kursar M., Bonhagen K., Fensterle J., Kohler A., Hurwitz R., Kamradt T., Kaufmann S.H., Mittrucker H.W. Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J. Exp. Med. 2002, 196:1585-1592.
14. Murakami M., Sakamoto A., Bender J., Kappler J., Marrack P. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl Acad. Sci. USA 2002, 99:8832-8837.
15. Furuichi Y., Tokuyama H., Ueha S., Kurachi M., Moriyasu F., Kakimi K. Depletion of CD25+CD4+ T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization. World J. Gastroenterol. 2005, 11:3772-3777.
16. Xu X.W., Lu M.H., Tan D.M. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin. Microbiol. Infect. 2005, 11:52-56.
17. Ke W.M., Ye Y.N., Huang S. Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B. J. Gastroenterol. 2003, 38:861-864.
18. Baecher-Allan C., Viglietta V., Hafler D.A. Human CD4+CD25+ regulatory T cells. Semin. Immunol. 2004, 16:89-98.
19. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 2001, 167:1245-1253.
20. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., Rudensky A.Y. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.